Type E – Dr Zainab Mohamed – Non Hodgkin’s Lymphoma Subtypes in Africa; HIV-Associated Multicentric Castleman’s Disease
A travel grant was awarded to Dr Zainab Mohamed from Department of Radiation Oncology, University of Cape Town/Groote Schuur Hospital to attend and present two posters at the AORTIC 2017 Conference in Kigali, Rwanda from 7th to 10th November 2017.
The major areas of study and how the visit have contributed to the understanding and/or management of cancer
I attended many sessions at this conference including but not limited to:
- Improving health systems: public health and economics: excellent talks delivered by, among others Prof Jennifer Moodley and Prof R Sankaranarayanan. Mellissa Wallace’s lecture on “Behavioral Science and Cancer Control” was particularly useful to understand patient-related barriers to accessing available care.
- Cancer registries: multiple sessions expanding on the state of cancer registries in Africa
- The launch of the NCCN harmonized clinical practice guidelines in Oncology: Sub-Saharan Africa Edition: An important resource for resource-limited environments
- Lymphoma, Haematology and HIV associated malignancies sessions: extremely valuable as I manage lymphomas at Groote Schuur Hospital and have a special interest in HIV-related malignancies
- Ethics in global oncology practice and research: excellent talks examining research ethics, conflicts of interest and ethics of biobanking. This is very relevant to our situation here where we are involved with pharma-sponsored studies, particularly as regards transfer of specimens, as well as self-initiated research.
AORTIC was an opportunity to show our work and meet others in Africa conducting research in the same area eg Satish Gopal from Malawi. I also attended a closed session on Oncology training in Africa where we discussed the need for a harmonized curriculum and we informed the group of opportunities for training at our institutions,
The most beneficial aspect of this trip was the networking and new relationships formed that will benefit clinical research and training at my institution.